Psychedelics Market Update: H1 2025 in Review
The psychedelic drugs market is emerging as a strategic investment opportunity in healthcare, with forecasts generally placing its value around US$6.4 billion
The psychedelic drugs market is emerging as a strategic investment opportunity in healthcare, with forecasts generally placing its value around US$6.4 billion
The US Federal Reserve held its fifth meeting of 2025 from Tuesday (July 29) to Wednesday (July 30) against a backdrop of
The canned cocktail maker High Noon is warning customers that some of its vodka seltzers were accidentally labeled as Celsius energy drinks.
President Donald Trump on Wednesday signed an executive order ending the de minimis trade loophole for low-value packages shipped from all countries. The
As the global push toward electrification accelerates, lithium remains a critical piece of the energy transition. Continued oversupply remained a persistent headwind
“Whatever is out of favor and hated at the moment, that’s probably what you need to buy,” he said. “Buy it when
From established players to up-and-coming firms, Canada’s pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working to discover and develop
When Canadian-Russian programmer Vitalik Buterin penned a white paper in 2013 outlining a new kind of blockchain platform, few could have predicted
July 29 (Reuters) – Union Pacific said on Tuesday it would buy smaller rival Norfolk Southern in an $85-billion deal to create